20h
Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms
Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in Cosmo’s Vision 2030, strengthening the ...
BC Assessment has disabled a new tool on its website that made the names of the owners of every property in the province ...
SAN BERNARDINO, CALIFORNIA / ACCESS Newswire / January 12, 2026 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF)(FSE:YE1) (Dateline or the Company) is pleased to announce drilling results at its 10 ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback